• PRASIDDHI R. RAIKAR Department of Pharmaceutics, KLE College of Pharmacy, Belagavi. A Constituent unit of KLE Academy of Higher Education and Research, Belagavi 590010, Karnataka, India
  • PANCHAXARI M. DANDAGI Department of Pharmaceutics, KLE College of Pharmacy, Belagavi. A Constituent unit of KLE Academy of Higher Education and Research, Belagavi 590010, Karnataka, India



Hydrophobic, Nanoparticulate, Polymer Micelles, Pluronic, Theranostic, Tolerance, Microenvironment


Popular cancer therapies face extreme disadvantages including multimedicament tolerance and non-target impact. These issues will lead to poorer patient conformity and poor levels of survival. Successful medical therapies for cancer patients are desperately required. Nano-particulate structures with a pluronic base represent revolutionary platforms for anti-cancer agent provision. These structures provide great potential for the advancement of cancer therapy due to their pharmacological properties and sufficient physicochemical characteristics. This review aims to offer a more detailed description of the pluronic drug delivery mechanisms that are currently available and explains pluronic as a medicinal polymer. Hydrophobic payload formulations and updated, targeted distribution mechanisms are explained based on pluronic formulations. This analysis offers a rundown of the current situation art related to the theranostic application of polymer micelles targeting the microenvironment of cancer cells. Some guidelines for the future scope and possible opportunities are also been addressed.

Search criteria: Primary sources such as Medline a principal component of PubMed, an online, searchable, and biomedical and life science research literature database is been used. It brings readers to almost any area of interest with research and journal articles. One of the internet resources of importance to get scientific publications is specialized scientific search engines known as Google Scholar a database of research material that can be searched for. I have used the online electronic access portal of Elsevier such as Science Direct to its publications. Scopus is the biggest abstract and peer- reviewed literature database for scientific journals, books, and conference work. Keywords like Cancer, Pluronic, Nanoparticles, Chemotherapy, Cancer, Theranostic, Targeted, Micelles, and Core-shell are crucial as they notify search engines of the content of the site.

Range of years: 1992-2020.


Download data is not yet available.


Pucci C, Martinelli C, Ciofani G. Innovative approaches for cancer treatment: current perspectives and new challenges. Ecancermedicalscience. 2019; 13.

Wadhwa A, Mathura V, Lewis SA. Emerging novel Nano pharmaceuticals for drug delivery. Asian J Pharm Clin Res. 2018; 11:35–42.

Jahan ST, Sadat S, Walliser M, Haddadi A. Targeted therapeutic nanoparticles: an immense promise to fight against cancer. J Drug Deliv. 2017; 2017.

Urruticoechea A, Alemany R, Balart J, Villanueva A, Viñals F, Capella G. Recent advances in cancer therapy: an overview. Curr Pharm Des. 2010; 16:3–10.

Williams GH, Stoeber K. The cell cycle and cancer. J Pathol. 2012; 226:352–64.

Meyers CA. How chemotherapy damages the central nervous system. J Biol. 2008; 7:11.

Ismaili N, Amzerin M, Flechon A. Chemotherapy in advanced bladder cancer: current status and future. J Hematol OncolJ Hematol Oncol. 2011; 4:35.

DeVita VT, Chu E. A history of cancer chemotherapy. Cancer Res. 2008; 68:8643–53.

Washington CM, Leaver DT. Principles and Practice of Radiation Therapy-E-Book. Elsevier Health Sciences; 2015.

Baskar R, Lee KA, Yeo R, Yeoh K-W. Cancer and radiation therapy: current advances and future directions. Int J Med Sci. 2012; 9:193.

Naef AP. Hugh Morriston Davies: first dissection lobectomy in 1912. Ann Thorac Surg. 1993; 56:988–9.

Phillips EH, Franklin M, Carroll BJ, Fallas MJ, Ramos R, Rosenthal D. Laparoscopic colectomy. Ann Surg. 1992; 216:703.

Singletary SE. Minimally invasive techniques in breast cancer treatment. In: Seminars in Surgical Oncology. Wiley Online Library; 2001. p. 246–50.

Sherwood JT, Brock MV. Lung cancer: new surgical approaches. Respirology. 2007; 12:326–32.

Hashizume M. MRI-guided laparoscopic and robotic surgery for malignancies. Int J Clin Oncol. 2007; 12:94–8.

Sun C, Fang C, Stephen Z, Veiseh O, Hansen S, Lee D, et al. Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles. 2008;

Chertok B, Moffat BA, David AE, Yu F, Bergemann C, Ross BD, et al. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials. 2008; 29:487–96.

Dhar S, Gu FX, Langer R, Farokhzad OC, Lippard SJ. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized prodrug-PLGA–PEG nanoparticles. Proc Natl Acad Sci. 2008; 105:17356–61.

Fayter D, Corbett M, Heirs M, Fox D, Eastwood A. A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett’s oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin. In: NIHR Health Technology Assessment Programme: Executive Summaries. NIHR Journals Library; 2010.

Huang X, Jain PK, El-Sayed IH, El-Sayed MA. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med Sci. 2008; 23:217.

Griffin RJ, Dings RP, Jamshidi-Parsian A, Song CW. Mild temperature hyperthermia and radiation therapy: role of tumour vascular thermotolerance and relevant physiological factors. Int J Hyperthermia. 2010; 26:256–63.

Hurwitz MD. Today’s thermal therapy: Not your father’s hyperthermia: Challenges and opportunities in application of hyperthermia for the 21st century cancer patient. Am J Clin Oncol. 2010; 33:96–100.

Jordan A, Scholz R, Maier-Hauff K, van Landeghem FK, Waldoefner N, Teichgraeber U, et al. The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma. J Neurooncol. 2006; 78:7–14.

Kawai N, Ito A, Nakahara Y, Futakuchi M, Shirai T, Honda H, et al. Anticancer effect of hyperthermia on prostate cancer mediated by magnetite cationic liposomes and immune‐response induction in transplanted syngeneic rats. The prostate. 2005; 64:373–81.

Maier-Hauff K, Rothe R, Scholz R, Gneveckow U, Wust P, Thiesen B, et al. Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J Neurooncol. 2007; 81:53–60.

Lehmann J, Natarajan A, DeNardo GL, Ivkov R, Foreman AR, Catapano C, et al. Nanoparticle thermotherapy and external beam radiation therapy for human prostate cancer cells. Cancer Biother Radiopharm. 2008; 23:265–71.

Dudley ME, Yang JC, Sherry R, Hughes MS, Royal R, Kammula U, et al. Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. J Clin Oncol. 2008; 26:5233.

Rosenberg SA, Dudley ME. Adoptive cell therapy for the treatment of patients with metastatic melanoma. Curr Opin Immunol. 2009; 21:233–40.

Ren J, Di L, Song G, Yu J, Jia J, Zhu Y, et al. Selections of appropriate regimen of high-dose chemotherapy combined with adoptive cellular therapy with dendritic and cytokine-induced killer cells improved progression-free and overall survival in patients with metastatic breast cancer: reargument of such contentious therapeutic preferences. Clin Transl Oncol. 2013; 15:780–8.

Arruebo M, Vilaboa N, Sáez-Gutierrez B, Lambea J, Tres A, Valladares M, et al. Assessment of the evolution of cancer treatment therapies. Cancers. 2011; 3:3279–330.

Patil PM, Chaudhari PD, Sahu M, Duragkar NJ. Review article on gene therapy. Res J Pharmacol Pharmacodyn. 2012; 4:77–83.

Sanna V, Pala N, Sechi M. Targeted therapy using nanotechnology: focus on cancer. Int J Nanomedicine. 2014; 9:467.

Cisterna BA, Kamaly N, Choi WI, Tavakkoli A, Farokhzad OC, Vilos C. Targeted nanoparticles for colorectal cancer. Nanomed. 2016; 11:2443–56.

Yuan X, Kang C, Zhao Y, Gu M, Pu P, Tian N, et al. Surface multi-functionalization of poly (lactic acid) nanoparticles and c6 glioma cell targeting in vivo. Chin J Polym Sci. 2009; 27:231–9.

Zhou J, Romero G, Rojas E, Ma L, Moya S, Gao C. Layer by layer chitosan/alginate coatings on poly (lactide-co-glycolide) nanoparticles for antifouling protection and Folic acid binding to achieve selective cell targeting. J Colloid Interface Sci. 2010; 345:241–7.

Li Z, Tan S, Li S, Shen Q, Wang K. Cancer drug delivery in the nano era: An overview and perspectives. Oncol Rep. 2017; 38:611–24.

Hemant K, Raizaday A, Sivadasu P, Uniyal S, Kumar SH. Cancer nanotechnology: nanoparticulate drug delivery for the treatment of cancer. Int J Pharm Pharm Sci. 2015; 7:40–6.

Autio KA, Garcia JA, Alva AS, Hart LL, Milowsky MI, Posadas EM, et al. A phase 2 study of BIND-014 (PSMA-targeted docetaxel nanoparticle) administered to patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC). American Society of Clinical Oncology; 2016.

Elsabahy M, Wooley KL. Design of polymeric nanoparticles for biomedical delivery applications. Chem Soc Rev. 2012; 41:2545–61.

Mohamed F, van der Walle CF. Engineering biodegradable polyester particles with specific drug targeting and drug release properties. J Pharm Sci. 2008; 97:71–87.

Danhier F, Feron O, Préat V. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Controlled Release. 2010; 148:135–46.

Pelicano H, Martin DS, Xu RH, Huang P. Glycolysis inhibition for anticancer treatment. Oncogene. 2006; 25:4633–46.

Bazak R, Houri M, El Achy S, Hussein W, Refaat T. Passive targeting of nanoparticles to cancer: A comprehensive review of the literature. Mol Clin Oncol. 2014; 2:904–8.

Cengelli F, Maysinger D, Tschudi-Monnet F, Montet X, Corot C, Petri-Fink A, et al. Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structures. J Pharmacol Exp Ther. 2006; 318:108–16.

Jokerst JV, Lobovkina T, Zare RN, Gambhir SS. Nanoparticle PEGylation for imaging and therapy. Nanomed. 2011; 6:715–28.

Moghimi SM, Hunter AC. Poloxamers and poloxamines in nanoparticle engineering and experimental medicine. Trends Biotechnol. 2000; 18:412–20.

Shirshahi V, Shamsipour F, Zarnani AH, Verdi J, Saber R. Active targeting of HER2-positive breast cancer cells by Herceptin-functionalized organically modified silica nanoparticles. Cancer Nanotechnol. 2013; 4:27–37.

Yang Z, Kang S, Zhou R. Nanomedicine: de novo design of nanodrugs. Nanoscale. 2014; 6:663–77.

Muro S. Challenges in design and characterization of ligand-targeted drug delivery systems. J Controlled Release. 2012; 164:125–37.

Wang J, Tian S, Petros RA, Napier ME, DeSimone JM. The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies. J Am Chem Soc. 2010; 132:11306–13.

Lee H, Fonge H, Hoang B, Reilly RM, Allen C. The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles. Mol Pharm. 2010; 7:1195–208.

Xin H, Jiang X, Gu J, Sha X, Chen L, Law K, et al. Angiopep-conjugated poly (ethylene glycol)-co-poly (ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Biomaterials. 2011; 32:4293–305.

Kim B-J, Im S-S, Oh S-G. Investigation on the solubilization locus of aniline-HCl salt in SDS micelles with 1H NMR spectroscopy. Langmuir. 2001; 17:565–6.

Sun B, Ranganathan B, Feng S-S. Multifunctional poly (D, L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer. Biomaterials. 2008; 29:475–86.

Cruz LJ, Tacken PJ, Fokkink R, Joosten B, Stuart MC, Albericio F, et al. Targeted PLGA nano-but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro. J Controlled Release. 2010; 144:118–26.

Dhar S, Gu FX, Langer R, Farokhzad OC, Lippard SJ. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt (IV) prodrug-PLGA–PEG nanoparticles. Proc Natl Acad Sci. 2008; 105:17356–61.

Torchilin V. Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev. 2011; 63:131–5.

Wang Z, Chui W-K, Ho PC. Design of a multifunctional PLGA nanoparticulate drug delivery system: evaluation of its physicochemical properties and anticancer activity to malignant cancer cells. Pharm Res. 2009; 26:1162–71.

Farokhzad OC, Cheng J, Teply BA, Sherifi I, Jon S, Kantoff PW, et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci. 2006; 103:6315–20.

Esmaeili F, Ghahremani MH, Ostad SN, Atyabi F, Seyedabadi M, Malekshahi MR, et al. Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA–PEG–folate conjugate. J Drug Target. 2008; 16:415–23.

Tiwari S, Kansara V, Bahadur P. Targeting anticancer drugs with pluronic aggregates: Recent updates. Int J Pharm. 2020; 119544.

Akash MSH, Rehman K. Recent progress in biomedical applications of Pluronic (PF127): Pharmaceutical perspectives. J Controlled Release. 2015; 209:120–38.

Bodratti AM, Sarkar B, Alexandridis P. Adsorption of poly (ethylene oxide)-containing amphiphilic polymers on solid-liquid interfaces: Fundamentals and applications. Adv Colloid Interface Sci. 2017; 244:132–63.

Lahiri B, Mukhopadhyay SD. Credibility of Farm Information Disseminated Through Newspapers and Radio Programme: A Case Study. Indian Res J Ext Educ. 2016; 13:1–8.

Yang L, Alexandridis P. Physicochemical aspects of drug delivery and release from polymer-based colloids. Curr Opin Colloid Interface Sci. 2000; 5:132–43.

Alexandridis P. Gold nanoparticle synthesis, morphology control, and stabilization facilitated by functional polymers. Chem Eng Technol. 2011; 34:15–28.

Agnely F, Djedour A, Bochot A, Grossiord J-L. Properties of various thermoassociating polymers: pharmaceutical and cosmetic applications. J Drug Deliv Sci Technol. 2006; 16:3–10.

Tadros T. Viscoelastic properties of sterically stabilised emulsions and their stability. Adv Colloid Interface Sci. 2015; 222:692–708.

Tadros TF. Interfacial Phenomena and Colloid Stability: Industrial Applications. Walter de Gruyter GmbH & Co KG; 2015.

Chang Y, Chu W-L, Chen W-Y, Zheng J, Liu L, Ruaan R-C, et al. A systematic SPR study of human plasma protein adsorption behavior on the controlled surface packing of self‐assembled poly (ethylene oxide) triblock copolymer surfaces. J Biomed Mater Res Part Off J Soc Biomater Jpn Soc Biomater Aust Soc Biomater Korean Soc Biomater. 2010; 93:400–8.

Alvarez-Lorenzo C, Sosnik A, Concheiro A. PEO-PPO block copolymers for passive micellar targeting and overcoming multidrug resistance in cancer therapy. Curr Drug Targets. 2011; 12:1112–30.

Singh-Joy SD, McLain VC. Safety assessment of poloxamers. Int J Toxicol. 2008; 27:93–128.

Grindel JM, Jaworski T, Piraner O, Emanuele RM, Balasubramanian M. Distribution, metabolism, and excretion of a novel surface‐active agent, purified poloxamer 188, in rats, dogs, and humans. J Pharm Sci. 2002; 91:1936–47.

Batrakova E, Lee S, Li S, Venne A, Alakhov V, Kabanov A. Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells. Pharm Res. 1999; 16:1373–9.

Venne A, Li S, Mandeville R, Kabanov A, Alakhov V. Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells. Cancer Res. 1996; 56:3626–9.

Kabanov AV, Batrakova EV, Alakhov VY. Pluronic® block copolymers for overcoming drug resistance in cancer. Adv Drug Deliv Rev. 2002; 54:759–79.

Altan N, Chen Y, Schindler M, Simon SM. Defective acidification in human breast tumor cells and implications for chemotherapy. J Exp Med. 1998; 187:1583–98.

Breuninger LM, Paul S, Gaughan K, Miki T, Chan A, Aaronson SA, et al. Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res. 1995; 55:5342–7.

Clary I, Doherty G, Moran E, Clynes M. The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems. Biochem Pharmacol. 1997; 53:1493–502.

Nooter K, Stoter G. Molecular mechanisms of multidrug resistance in cancer chemotherapy. Pathol-Res Pract. 1996; 192:768–80.

Shapiro AB, Fox K, Lee P, Yang YD, Ling V. Functional intracellular P‐glycoprotein. Int J Cancer. 1998; 76:857–64.

Benderra Z, Morjani H, Trussardi A, Manfait M. Role of the vacuolar H+-ATPase in daunorubicin distribution in etoposide-resistant MCF7 cells overexpressing the multidrug-resistance associated protein. Int J Oncol. 1998; 12:711–6.

Woo Jung Y, Lee H, Yeon Kim J, Jin Koo E, Sang Oh K, Hong Yuk S. Pluronic-based core/shell nanoparticles for drug delivery and diagnosis. Curr Med Chem. 2013; 20:3488–99.

Aydin F, Chu X, Uppaladadium G, Devore D, Goyal R, Murthy NS, et al. Self-assembly and critical aggregation concentration measurements of ABA triblock copolymers with varying B block types: model development, prediction, and validation. J Phys Chem B. 2016; 120:3666–76.

Srinivas G, Discher DE, Klein ML. Self-assembly and properties of diblock copolymers by coarse-grain molecular dynamics. Nat Mater. 2004; 3:638–44.

Nawaz S, Carbone P. Coarse-graining poly (ethylene oxide)–poly (propylene oxide)–poly (ethylene oxide) (PEO–PPO–PEO) block copolymers using the MARTINI force field. J Phys Chem B. 2014; 118:1648–59.

Bressel K, Gradzielski M. Enhancing the stability of spontaneously self-assembled vesicles–the effect of polymer architecture. Soft Matter. 2015; 11:2445–53.

Bryskhe K, Jansson J, Topgaard D, Schillen K, Olsson U. Spontaneous vesicle formation in a block copolymer system. J Phys Chem B. 2004; 108:9710–9.

Nagarajan R. “Non-equilibrium” block copolymer micelles with glassy cores: A predictive approach based on theory of equilibrium micelles. J Colloid Interface Sci. 2015; 449:416–27.

Bouchemal K, Agnely F, Koffi A, Ponchel G. A concise analysis of the effect of temperature and propanediol-1, 2 on Pluronic F127 micellization using isothermal titration microcalorimetry. J Colloid Interface Sci. 2009; 338:169–76.

Liang X, Guo C, Ma J, Wang J, Chen S, Liu H. Temperature-dependent aggregation and disaggregation of poly (ethylene oxide)-poly (propylene oxide)-poly (ethylene oxide) block copolymer in aqueous solution. J Phys Chem B. 2007; 111(46):13217–20.

Ganguly R, Aswal VK, Hassan PA, Gopalakrishnan IK, Yakhmi JV. Sodium chloride and ethanol induced sphere to rod transition of triblock copolymer micelles. J Phys Chem B. 2005; 109:5653–8.

Narang P, Yadav N, Venkatesu P. Scrutinizing the effect of various nitrogen containing additives on the micellization behavior of a triblock copolymer. J Colloid Interface Sci. 2019; 553:655–65.

Parekh P, Dey J, Kumar S, Nath S, Ganguly R, Aswal VK, et al. Butanol solubilization in aqueous F127 solution: Investigating the enhanced micellar solvation and consequent improvement in gelation characteristics. Colloids Surf B Biointerfaces. 2014; 114:386–91.

Bharatiya B, Aswal VK, Hassan PA, Bahadur P. Influence of a hydrophobic diol on the micellar transitions of Pluronic P85 in aqueous solution. J Colloid Interface Sci. 2008; 320:452–9.

Lee C-F, Yang C-H, Lin T-L, Bahadur P, Chen L-J. Role of molecular weight and hydrophobicity of amphiphilic tri-block copolymers in temperature-dependent co-micellization process and drug solubility. Colloids Surf B Biointerfaces. 2019; 183:110461.

Wang Q, Li L, Jiang S. Effects of a PPO− PEO− PPO triblock copolymer on micellization and gelation of a PEO− PPO− PEO triblock copolymer in aqueous solution. Langmuir. 2005; 21:9068–75.

Sarkar B, Ravi V, Alexandridis P. Micellization of amphiphilic block copolymers in binary and ternary solvent mixtures. J Colloid Interface Sci. 2013; 390:137–46.

Lai TC, Kataoka K, Kwon GS. Pluronic-based cationic block copolymer for forming pDNA polyplexes with enhanced cellular uptake and improved transfection efficiency. Biomaterials. 2011; 32:4594–603.

Lu Y, Zhang X, Fan Z, Du B. Adsorption of PNIPAm110-PEO100-PPO65-PEO100-PNIPAm110 pentablock terpolymer on hydrophobic gold. Polymer. 2012; 53:3791–801.

Cho E-B, Choi E, Yang S, Jaroniec M. Hollow mesoporous organosilica nanospheres templated with flower-like micelles of pentablock copolymers. J Colloid Interface Sci. 2018; 528:124–34.

Vyas B, Pillai SA, Tiwari S, Bahadur P. Effects of head group and counter-ion variation in cationic surfactants on the microstructures of EO-PO block copolymer micelles. Colloid Interface Sci Commun. 2019; 33:100216.

Chen C-Y, Wang Y-C, Hung C-C. In vitro dual-modality chemo-photodynamic therapy via stimuli-triggered polymeric micelles. React Funct Polym. 2016; 98:56–64.

Gan H, Chen L, Sui X, Wu B, Zou S, Li A, et al. Enhanced delivery of sorafenib with anti-GPC3 antibody-conjugated TPGS-b-PCL/Pluronic P123 polymeric nanoparticles for targeted therapy of hepatocellular carcinoma. Mater Sci Eng C. 2018; 91:395–403.

Hao J, Tong T, Jin K, Zhuang Q, Han T, Bi Y, et al. Folic acid-functionalized drug delivery platform of resveratrol based on Pluronic 127/D-α-tocopheryl polyethylene glycol 1000 succinate mixed micelles. Int J Nanomedicine. 2017; 12:2279.

Xiong XY, Pan X, Tao L, Cheng F, Li ZL, Gong YC, et al. Enhanced effect of folated pluronic F87-PLA/TPGS mixed micelles on targeted delivery of paclitaxel. Int J Biol Macromol. 2017; 103:1011–8.

Lübtow MM, Haider MS, Kirsch M, Klisch S, Luxenhofer R. Like dissolves like? A comprehensive evaluation of partial solubility parameters to predict polymer–drug compatibility in ultrahigh drug-loaded polymer micelles. Biomacromolecules. 2019; 20:3041–56.

Xiao B, Zhang M, Viennois E, Zhang Y, Wei N, Baker MT, et al. Inhibition of MDR1 gene expression and enhancing cellular uptake for effective colon cancer treatment using dual-surface-functionalized nanoparticles. Biomaterials. 2015; 48:147–60.

Zhang Y, Song W, Geng J, Chitgupi U, Unsal H, Federizon J, et al. Therapeutic surfactant-stripped frozen micelles. Nat Commun. 2016; 7:1–9.

Kim B-J, Im S-S, Oh S-G. Investigation on the solubilization locus of aniline-HCl salt in SDS micelles with 1H NMR spectroscopy. Langmuir. 2001; 17:565–6.

Jackson JK, Springate CM, Hunter WL, Burt HM. Neutrophil activation by plasma opsonized polymeric microspheres: inhibitory effect of Pluronic F127. Biomaterials. 2000; 21:1483–91.

Lee ES, Oh YT, Youn YS, Nam M, Park B, Yun J, et al. Binary mixing of micelles using Pluronics for a nano-sized drug delivery system. Colloids Surf B Biointerfaces. 2011; 82:190–5.

Tiwari S, Tirosh B, Rubinstein A. Increasing the affinity of cationized polyacrylamide-paclitaxel nanoparticles towards colon cancer cells by a surface recognition peptide. Int J Pharm. 2017; 531:281–91.

Luo YY, Xiong XY, Cheng F, Gong YC, Li ZL, Li YP. The targeting properties of folate-conjugated pluronic F127/poly (lactic-co-glycolic) nanoparticles. Int J Biol Macromol. 2017; 105:711–9.

Song H, He R, Wang K, Ruan J, Bao C, Li N, et al. Anti-HIF-1α antibody-conjugated pluronic triblock copolymers encapsulated with Paclitaxel for tumor targeting therapy. Biomaterials. 2010; 31:2302–12.

Zhang W, Shi Y, Chen Y, Ye J, Sha X, Fang X. Multifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors. Biomaterials. 2011; 32:2894–906.

Minko T, Batrakova EV, Li S, Li Y, Pakunlu RI, Alakhov VY, et al. Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells. J Controlled Release. 2005; 105:269–78.

Alakhova DY, Kabanov AV. Pluronics and MDR reversal: an update. Mol Pharm. 2014; 11:2566–78.

Khaliq NU, Park DY, Yun BM, Jung YW, Seo JH, Hwang CS, et al. Pluronics: intelligent building units for targeted cancer therapy and molecular imaging. Int J Pharm. 2019; 556:30–44.

Li Z, Qiu L, Chen Q, Hao T, Qiao M, Zhao H, et al. pH-sensitive nanoparticles of poly (l-histidine)–poly (lactide-co-glycolide)–tocopheryl polyethylene glycol succinate for anti-tumor drug delivery. Acta Biomater. 2015; 11:137–50.

Wu W, Wang J, Lin Z, Li X, Li J. Tumor‐Acidity Activated Surface Charge‐Conversion of Polymeric Nanocarriers for Enhanced Cell Adhesion and Targeted Drug Release. Macromol Rapid Commun. 2014; 35:1679–84.

Lee ES, Gao Z, Bae YH. Recent progress in tumor pH targeting nanotechnology. J Controlled Release. 2008; 132:164–70.

Liang Y, Su Z, Yao Y, Zhang N. Preparation of pH sensitive Pluronic-docetaxel conjugate micelles to balance the stability and controlled release issues. Materials. 2015; 8:379–91.

Liu J, Huang Y, Kumar A, Tan A, Jin S, Mozhi A, et al. pH-sensitive nano-systems for drug delivery in cancer therapy. Biotechnol Adv. 2014; 32:693–710.

Xu C, Xu J, Zheng Y, Fang Q, Lv X, Wang X, et al. Active-targeting and acid-sensitive pluronic prodrug micelles for efficiently overcoming MDR in breast cancer. J Mater Chem B. 2020; 8:2726–37.

Golwala P, Rathod S, Patil R, Joshi A, Ray D, Aswal VK, et al. Effect of cosurfactant addition on phase behavior and microstructure of a water dilutable microemulsion. Colloids Surf B Biointerfaces. 2020; 186:110736.

Cheng X, Zeng X, Zheng Y, Fang Q, Wang X, Wang J, et al. pH-sensitive pluronic micelles combined with oxidative stress amplification for enhancing multidrug resistance breast cancer therapy. J Colloid Interface Sci. 2020; 565:254–69.

Wang H, Jiang H, Corbet C, de Mey S, Law K, Gevaert T, et al. Piperlongumine increases sensitivity of colorectal cancer cells to radiation: Involvement of ROS production via dual inhibition of glutathione and thioredoxin systems. Cancer Lett. 2019; 450:42–52.

Deepagan VG, Kwon S, You DG, Um W, Ko H, Lee H, et al. In situ diselenide-crosslinked polymeric micelles for ROS-mediated anticancer drug delivery. Biomaterials. 2016; 103:56–66.

Ji S, Xia J, Xu H. Dynamic chemistry of selenium: Se–N and Se–Se dynamic covalent bonds in polymeric systems. ACS Publications; 2016.

Tong R, Lu X, Xia H. A facile mechanophore functionalization of an amphiphilic block copolymer towards remote ultrasound and redox dual stimulus responsiveness. Chem Commun. 2014; 50:3575–8.

Li F, Xie C, Cheng Z, Xia H. Ultrasound responsive block copolymer micelle of poly (ethylene glycol)–poly (propylene glycol) obtained through click reaction. Ultrason Sonochem. 2016; 30:9–17.

Huang A, Zheng H, Wu Z, Chen M, Huang Y. Circular RNA-protein interactions: functions, mechanisms, and identification. Theranostics. 2020; 10:3503.

Luo L, Zhang Q, Luo Y, He Z, Tian X, Battaglia G. Thermosensitive nanocomposite gel for intra-tumoral two-photon photodynamic therapy. J Controlled Release. 2019; 298:99–109.

Mukerji R, Schaal J, Li X, Bhattacharyya J, Asai D, Zalutsky MR, et al. Spatiotemporally photoradiation-controlled intratumoral depot for combination of brachytherapy and photodynamic therapy for solid tumor. Biomaterials. 2016; 79:79–87.

Shi S, Zhang L, Zhu M, Wan G, Li C, Zhang J, et al. Reactive oxygen species-responsive nanoparticles based on peglated prodrug for targeted treatment of oral tongue squamous cell carcinoma by combining photodynamic therapy and chemotherapy. ACS Appl Mater Interfaces. 2018; 10:29260–72.

Uthaman S, Pillarisetti S, Mathew AP, Kim Y, Bae WK, Huh KM, et al. Long circulating photoactivable nanomicelles with tumor localized activation and ROS triggered self-accelerating drug release for enhanced locoregional chemo-photodynamic therapy. Biomaterials. 2020; 232:119702.

Torchilin VP. Structure and design of polymeric surfactant-based drug delivery systems. J Controlled Release. 2001; 73:137–72.

Wang Y, Yu L, Han L, Sha X, Fang X. Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines. Int J Pharm. 2007; 337:63–73.

Zhang W, Shi Y, Chen Y, Yu S, Hao J, Luo J, et al. Enhanced antitumor efficacy by paclitaxel-loaded pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistance. Eur J Pharm Biopharm. 2010; 75:341–53.

Jain TK, Richey J, Strand M, Leslie-Pelecky DL, Flask CA, Labhasetwar V. Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomaterials. 2008; 29:4012–21.

Jain TK, Morales MA, Sahoo SK, Leslie-Pelecky DL, Labhasetwar V. Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol Pharm. 2005; 2:194–205.

Liu T-Y, Hu S-H, Liu K-H, Shaiu R-S, Liu D-M, Chen S-Y. Instantaneous drug delivery of magnetic/thermally sensitive nanospheres by a high-frequency magnetic field. Langmuir. 2008; 24:13306–11.

Bae WK, Park MS, Lee JH, Hwang JE, Shim HJ, Cho SH, et al. Docetaxel-loaded thermoresponsive conjugated linoleic acid-incorporated poloxamer hydrogel for the suppression of peritoneal metastasis of gastric cancer. Biomaterials. 2013; 34:1433–41.

Li YP, Sun LZ, Xiong XY, Li ZL, Xing TK, Yao LH. Controlled Release Characteristics of PLA-Pluronic-PLA Nano-Sized Vesicles In Vitro. In: Advanced Materials Research. Trans Tech Publ; 2013. p. 493–7.

Lin H-R, Li Y-S, Lin Y-J. Novel microencapsulated Pluronic–chitosan nanomicelles for lung delivery. Colloid Polym Sci. 2016; 294:1209–16.

Zhang J, Li Y, Fang X, Zhou D, Wang Y, Chen M. TPGS-g-PLGA/Pluronic F68 mixed micelles for tanshinone IIA delivery in cancer therapy. Int J Pharm. 2014; 476:185–98.

Adams ML, Lavasanifar A, Kwon GS. Amphiphilic block copolymers for drug delivery. J Pharm Sci. 2003; 97:1343–55.

Bae YH, Yin H. Stability issues of polymeric micelles. J Controlled Release. 2008; 131:2–4.

Barratt G. Colloidal drug carriers: achievements and perspectives. Cell Mol Life Sci CMLS. 2003; 60:21–37.

Li Y, Kwon GS. Methotrexate esters of poly (ethylene oxide)-block-poly (2-hydroxyethyl-L-aspartamide). Part I: Effects of the level of methotrexate conjugation on the stability of micelles and on drug release. Pharm Res. 2000; 17:607–11.

Aliabadi HM, Shahin M, Brocks DR, Lavasanifar A. Disposition of drugs in block copolymer micelle delivery systems. Clin Pharmacokinet. 2008; 47:619–34.

Oh KS, Song JY, Cho SH, Lee BS, Kim SY, Kim K, et al. Paclitaxel-loaded Pluronic nanoparticles formed by a temperature-induced phase transition for cancer therapy. J Controlled Release. 2010; 148:344–50.

Lee KE, Kim BK, Yuk SH. Biodegradable polymeric nanospheres formed by temperature-induced phase transition in a mixture of poly (lactide-co-glycolide) and poly (ethylene oxide)− poly (propylene oxide)− poly (ethylene oxide) triblock copolymer. Biomacromolecules. 2002; 3:1115–9.

Gautier S, Grudzielski N, Goffinet G, De Hassonville SH, Delattre L, Jérôme R. Preparation of poly (D, L-lactide) nanoparticles assisted by amphiphilic poly (methyl methacrylate-co-methacrylic acid) copolymers. J Biomater Sci Polym Ed. 2001; 12:429–50.

Yuk SH, Oh KS, Koo H, Jeon H, Kim K, Kwon IC. Multi-core vesicle nanoparticles based on vesicle fusion for delivery of chemotherapic drugs. Biomaterials. 2011; 32:7924–31.

Firestone MA, Wolf AC, Seifert S. Small-angle X-ray scattering study of the interaction of poly (ethylene oxide)-b-poly (propylene oxide)-b-poly (ethylene oxide) triblock copolymers with lipid bilayers. Biomacromolecules. 2003; 4:1539–49.

Oh KS, Kim K, Yoon BD, Lee HJ, Park DY, Kim E, et al. Docetaxel-loaded multilayer nanoparticles with nanodroplets for cancer therapy. Int J Nanomedicine. 2016; 11:1077.

Lu R-M, Chang Y-L, Chen M-S, Wu H-C. Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery. Biomaterials. 2011; 32:3265–74.

Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007; 2:751–60.

Gelperina S, Kisich K, Iseman MD, Heifets L. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med. 2005; 172:1487–90.

Haseeb MT, Khaliq NU, Yuk SH, Hussain MA, Bashir S. Linseed polysaccharides based nanoparticles for controlled delivery of docetaxel: design, in vitro drug release and cellular uptake. J Drug Deliv Sci Technol. 2019; 49:143–51.

Park JH, Saravanakumar G, Kim K, Kwon IC. Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv Drug Deliv Rev. 2010; 62:28–41.

Kozlov MY, Melik-Nubarov NS, Batrakova EV, Kabanov AV. Relationship between pluronic block copolymer structure, critical micellization concentration and partitioning coefficients of low molecular mass solutes. Macromolecules. 2000; 3:3305–13.

Alakhova DY, Zhao Y, Li S, Kabanov AV. Effect of doxorubicin/pluronic SP1049C on tumorigenicity, aggressiveness, DNA methylation and stem cell markers in murine leukemia. PloS One. 2013; 8:e72238.

Batrakova EV, Kabanov AV. Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Controlled Release. 2008; 130:98–106.

Valle JW, Lawrance J, Brewer J, Clayton A, Corrie P, Alakhov V, et al. A phase II, window study of SP1049C as first-line therapy in inoperable metastatic adenocarcinoma of the oesophagus. J Clin Oncol. 2004; 22:4195–4195.

Pitto-Barry A, Barry NP. Pluronic® block-copolymers in medicine: from chemical and biological versatility to rationalization and clinical advances. Polym Chem. 2014; 5:3291–7.

Maeda H. Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity. Adv Drug Deliv Rev. 2015; 91:3–6.

Oh KS, Lee H, Kim JY, Koo EJ, Lee EH, Park JH, et al. The multilayer nanoparticles formed by layer by layer approach for cancer-targeting therapy. J Controlled Release. 2013; 165:9–15.

Valle JW, Armstrong A, Newman C, Alakhov V, Pietrzynski G, Brewer J, et al. A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction. Invest New Drugs. 2011; 29:1029–37.

Krylova OO, Melik‐Nubarov NS, Badun GA, Ksenofontov AL, Menger FM, Yaroslavov AA. Pluronic L61 accelerates flip–flop and transbilayer doxorubicin permeation. Chem Eur J. 2003; 9:3930–6.

Batrakova EV, Li S, Brynskikh AM, Sharma AK, Li Y, Boska M, et al. Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers. J Controlled Release. 2010; 143:290–301.

Sun H, Meng Q, Tang S, Su J, Yin Q, Chen L, et al. Inhibition of Breast Cancer Metastasis by Pluronic Copolymers with Moderate Hydrophilic–Lipophilic Balance. Mol Pharm. 2015; 12:3323–31.

Zhu P, Zhao N, Sheng D, Hou J, Hao C, Yang X, et al. Inhibition of growth and metastasis of colon cancer by delivering 5-fluorouracil-loaded pluronic P85 copolymer micelles. Sci Rep. 2016; 6:1–11.

Cai Y, Sun Z, Fang X, Fang X, Xiao F, Wang Y, et al. Synthesis, characterization and anti-cancer activity of Pluronic F68–curcumin conjugate micelles. Drug Deliv. 2016; 23:2587–95.

Nguyen DH, Bae JW, Choi JH, Lee JS, Park KD. Bioreducible cross-linked Pluronic micelles: pH-triggered release of doxorubicin and folate-mediated cellular uptake. J Bioact Compat Polym. 2013; 28:341–54.

Xiong XY, Tao L, Qin X, Li ZL, Gong YC, Li YP, et al. Novel folated Pluronic/poly (lactic acid) nanoparticles for targeted delivery of paclitaxel. RSC Adv. 2016; 6:52729–38.

Kim J-Y, Choi WI, Kim YH, Tae G. Brain-targeted delivery of protein using chitosan-and RVG peptide-conjugated, pluronic-based nano-carrier. Biomaterials. 2013; 34:1170–8.

Huang Y, Liu W, Gao F, Fang X, Chen Y. c (RGDyK)-decorated Pluronic micelles for enhanced doxorubicin and paclitaxel delivery to brain glioma. Int J Nanomedicine. 2016; 11:1629.

Domingues C, Alvarez-Lorenzo C, Concheiro A, Veiga F, Figueiras A. Nanotheranostic Pluronic-like polymeric micelles: shedding light into the dark shadows of tumors. Mol Pharm. 2019; 16:4757–74.

Jo Y, Choi N, Kim K, Koo H-J, Choi J, Kim HN. Chemoresistance of cancer cells: requirements of tumor microenvironment-mimicking in vitro models in anti-cancer drug development. Theranostics. 2018; 8:5259.

Wang M, Zhao J, Zhang L, Wei F, Lian Y, Wu Y, et al. Role of tumor microenvironment in tumorigenesis. J Cancer. 2017; 8:761.

Domingues CS da C, Serambeque BP, Laranjo Cândido MS, Marto CMM, Veiga FJ de B, Sarmento Antunes Cruz Ribeiro AB, et al. Epithelial‐mesenchymal transition and microRNAs: Challenges and future perspectives in oral cancer. Head Neck. 2018; 40:2304–13.

Zhu X, Anquillare EL, Farokhzad OC, Shi J. Polymer-and protein-based nanotechnologies for cancer theranostics. In: Cancer Theranostics. Elsevier; 2014. p. 419–36.

Jo SD, Ku SH, Won Y-Y, Kim SH, Kwon IC. Targeted nanotheranostics for future personalized medicine: recent progress in cancer therapy. Theranostics. 2016; 6:1362.

Ma Y, Huang J, Song S, Chen H, Zhang Z. Cancer‐targeted nanotheranostics: recent advances and perspectives. Small. 2016; 12:4936–54.

Giacomelli FC, Stepánek P, Schmidt V, Jäger E, Jäger A, Giacomelli C. Light scattering evidence of selective protein fouling on biocompatible block copolymer micelles. Nanoscale. 2012; 4:4504–14.

Oh KS, Han H, Yoon BD, Lee M, Kim H, Seo DW, et al. Effect of HIFU treatment on tumor targeting efficacy of docetaxel-loaded Pluronic nanoparticles. Colloids Surf B Biointerfaces. 2014; 119:137–44.

Zhang Y, Feng L, Wang J, Tao D, Liang C, Cheng L, et al. Surfactant‐Stripped Micelles of Near Infrared Dye and Paclitaxel for Photoacoustic Imaging Guided Photothermal‐Chemotherapy. Small. 2018; 14:1802991.

Zhang Y, Feng L, Wang J, Tao D, Liang C, Cheng L, et al. Surfactant‐Stripped Micelles of Near Infrared Dye and Paclitaxel for Photoacoustic Imaging Guided Photothermal‐Chemotherapy. Small. 2018; 14:1802991.

Nagy-Simon T, Potara M, Craciun A-M, Licarete E, Astilean S. IR780-dye loaded gold nanoparticles as new near infrared activatable nanotheranostic agents for simultaneous photodynamic and photothermal therapy and intracellular tracking by surface enhanced resonant Raman scattering imaging. J Colloid Interface Sci. 2018; 517:239–50.

Pellosi DS, Calori IR, de Paula LB, Hioka N, Quaglia F, Tedesco AC. Multifunctional theranostic Pluronic mixed micelles improve targeted photoactivity of Verteporfin in cancer cells. Mater Sci Eng C. 2017; 71:1–9.

Sokolov IL, Cherkasov VR, Tregubov AA, Buiucli SR, Nikitin MP. Smart materials on the way to theranostic nanorobots: molecular machines and nanomotors, advanced biosensors, and intelligent vehicles for drug delivery. Biochim Biophys Acta BBA-Gen Subj. 2017; 1861:1530–44.

Oba M. Study on development of polymeric micellar gene carrier and evaluation of its functionality. Biol Pharm Bull. 2013; 36:1045–51.

Varela-Moreira A, Shi Y, Fens MH, Lammers T, Hennink WE, Schiffelers RM. Clinical application of polymeric micelles for the treatment of cancer. Mater Chem Front. 2017; 1:1485–501.

Hua S, De Matos MB, Metselaar JM, Storm G. Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization. Front Pharmacol. 2018; 9:790.

Wong JK, Mohseni R, Hamidieh AA, MacLaren RE, Habib N, Seifalian AM. Limitations in clinical translation of nanoparticle-based gene therapy. Trends Biotechnol. 2017; 35:1124–5.

Pellosi DS, Calori IR, de Paula LB, Hioka N, Quaglia F, Tedesco AC. Multifunctional theranostic Pluronic mixed micelles improve targeted photoactivity of Verteporfin in cancer cells. Mater Sci Eng C. 2017; 71:1–9.

Kadian R. Nanoparticles: A promising drug delivery approach. Asian J Pharm Clin Res. 2018; 11:30–5.



How to Cite




Review Article(s)